Clinical Trials Browser

Triple Negative Breast Neoplasms

Pancreatic Cystic Neoplasm

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

CLDN18.2 Positive

Hodgkin Disease

Urinary Bladder Neoplasms

Rhabdoid Tumor

Lung Diseases, Interstitial

Advanced Squamous Non-Small Cell Lung Cancer

Non-Muscle Invasive Bladder Neoplasms

Advanced Biliary Tract Cancer(BTC)

Lymphoma, Large B-Cell, Diffuse

Liver Neoplasms

Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Nasopharyngeal Carcinoma

CLDN18.2-positive Advanced Biliary Tract Cancer

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Pancreatic Neoplasms

Biliary Tract Neoplasms

PDAC - Pancreatic Ductal Adenocarcinoma

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Biliary Tract Neoplasms

Biliary Tract Neoplasms, Cholangiocarcinoma

Nasopharyngeal Neoplasms, Recurrence

Pancreatic Neoplasms

Bile Duct Neoplasms

Thyroid Neoplasms

Pancreatic Neoplasms

Nasopharyngeal Neoplasms

Gallbladder Cancer Unresectable

Biliary Tract Neoplasms

Cholangiocarcinoma

Advanced Solid Tumor

Pancreatic Neoplasms

Nasopharyngeal Carcinoma

Anophthalmia with pulmonary hypoplasia, Pancreatic Neoplasms

Nasopharyngeal Carcinoma

Pancreatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Locally Advanced Pancreatic Cancer

Pancreatic Neoplasms

Clinical Trials

Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

TRIFECTA

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

CECYDE

Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy

NOBLE

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma

Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

OHAI-NMIBC-01

No Acronym

ORIGIN2

Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

The Safety and Efficacy of Benmelstobart Injection in Patients With Advanced Biliary Tract Malignant Tumors

PANORAMIX

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer

TisGCS for BTC

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Ablatio

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

SPRING

SASAN-SPARING

Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer

NEOLANGIO

Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer

Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients

POLO

Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)

AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer